Literature DB >> 11803519

Patterns of dysmorphic features in schizophrenia.

L E Scutt1, E W Chow, R Weksberg, W G Honer, A S Bassett.   

Abstract

Congenital dysmorphic features are prevalent in schizophrenia and may reflect underlying neurodevelopmental abnormalities. A cluster analysis approach delineating patterns of dysmorphic features has been used in genetics to classify individuals into more etiologically homogeneous subgroups. In the present study, this approach was applied to schizophrenia, using a sample with a suspected genetic syndrome as a testable model. Subjects (n = 159) with schizophrenia or schizoaffective disorder were ascertained from chronic patient populations (random, n = 123) or referred with possible 22q11 deletion syndrome (referred, n = 36). All subjects were evaluated for presence or absence of 70 reliably assessed dysmorphic features, which were used in a three-step cluster analysis. The analysis produced four major clusters with different patterns of dysmorphic features. Significant between-cluster differences were found for rates of 37 dysmorphic features (P < 0.05), median number of dysmorphic features (P = 0.0001), and validating features not used in the cluster analysis: mild mental retardation (P = 0.001) and congenital heart defects (P = 0.002). Two clusters (1 and 4) appeared to represent more developmental subgroups of schizophrenia with elevated rates of dysmorphic features and validating features. Cluster 1 (n = 27) comprised mostly referred subjects. Cluster 4 (n = 18) had a different pattern of dysmorphic features; one subject had a mosaic Turner syndrome variant. Two other clusters had lower rates and patterns of features consistent with those found in previous studies of schizophrenia. Delineating patterns of dysmorphic features may help identify subgroups that could represent neurodevelopmental forms of schizophrenia with more homogeneous origins. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11803519      PMCID: PMC3142273          DOI: 10.1002/ajmg.1612

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  58 in total

1.  Centiles for adult head circumference.

Authors:  K M Bushby; T Cole; J N Matthews; J A Goodship
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

Review 2.  From neuropathology to neurodevelopment.

Authors:  D R Weinberger
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

3.  Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables.

Authors:  J J McGrath; J van Os; C Hoyos; P B Jones; I Harvey; R M Murray
Journal:  Schizophr Res       Date:  1995-12       Impact factor: 4.939

4.  Minor physical anomalies and behavior in preschool children.

Authors:  M F Waldrop; F A Pedersen; R Q Bell
Journal:  Child Dev       Date:  1968-06

5.  Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder.

Authors:  D D Weinstein; D Diforio; J Schiffman; E Walker; R Bonsall
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

6.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

7.  Formal analysis of dysmorphism: objective methods of syndrome definition.

Authors:  M Preus; S Aymé
Journal:  Clin Genet       Date:  1983-01       Impact factor: 4.438

Review 8.  Chromosomal abnormalities and schizophrenia.

Authors:  A S Bassett; E W Chow; R Weksberg
Journal:  Am J Med Genet       Date:  2000

Review 9.  A neurodevelopmental approach to the classification of schizophrenia.

Authors:  R M Murray; E O'Callaghan; D J Castle; S W Lewis
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

10.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01
View more
  8 in total

1.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

2.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

3.  Schizophrenia in an adult with 6p25 deletion syndrome.

Authors:  O Caluseriu; G Mirza; J Ragoussis; E W C Chow; D MacCrimmon; A S Bassett
Journal:  Am J Med Genet A       Date:  2006-06-01       Impact factor: 2.802

4.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

Review 5.  Schizophrenia and genetics: new insights.

Authors:  Anne S Bassett; Eva W Chow; Rosanna Weksberg; Linda Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

6.  The schizophrenia phenotype in 22q11 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Philip AbdelMalik; Mirona Gheorghiu; Janice Husted; Rosanna Weksberg
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

7.  Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease.

Authors:  Wai Lun Alan Fung; Eva W C Chow; Gary D Webb; Michael A Gatzoulis; Anne S Bassett
Journal:  Int J Cardiol       Date:  2008-01-11       Impact factor: 4.164

8.  Postmaturity in a genetic subtype of schizophrenia.

Authors:  E W C Chow; J Husted; R Weksberg; A S Bassett
Journal:  Acta Psychiatr Scand       Date:  2003-10       Impact factor: 6.392

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.